Gene · 54890
Papers4,144
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,001 to 1,020 of 4,144
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| New insights for gynecological cancer therapies: from molecular mechanisms and clinical evidence to future directions. | Cancer Metastasis Rev | 2023 | 37368179 | PubTator, text mining | PubMed |
| Novel insights into mutual regulation between N6-methyladenosine modification and LncRNAs in tumors. | Cancer Cell Int | 2023 | 37365581 | PubTator, text mining | PubMed |
| Comprehensive analysis of differences in N6-methyladenosine RNA methylomes in Helicobacter pylori infection. | Front Cell Dev Biol | 2023 | 37363723 | PubTator, text mining | PubMed |
| Emerging Epigenetic and Posttranslational Mechanisms Controlling Resistance to Glucocorticoids in Acute Lymphoblastic Leukemia. | Hemasphere | 2023 | 37359189 | PubTator, text mining | PubMed |
| METTL3-mediated m6A modification of SIRT1 mRNA inhibits progression of endometriosis by cellular senescence enhancing. | J Transl Med | 2023 | 37353804 | PubTator, text mining | PubMed |
| Roles and implications of mRNA N6 -methyladenosine in cancer. | Cancer Commun (Lond) | 2023 | 37350762 | PubTator, text mining | PubMed |
| Small RNA modifications: regulatory molecules and potential applications. | J Hematol Oncol | 2023 | 37349851 | PubTator, text mining | PubMed |
| Functional polymorphisms of the TET1 gene increase the risk of neuroblastoma in Chinese children. | J Cell Mol Med | 2023 | 37347215 | PubTator, text mining | PubMed |
| METTL3 regulates N6-methyladenosine modification of ANGPTL3 mRNA and potentiates malignant progression of stomach adenocarcinoma. | BMC Gastroenterol | 2023 | 37344779 | PubTator, text mining | PubMed |
| Epigenetics: Novel crucial approach for osteogenesis of mesenchymal stem cells. | J Tissue Eng | 2023 | 37342486 | PubTator, text mining | PubMed |
| METTL16 promotes glycolytic metabolism reprogramming and colorectal cancer progression. | J Exp Clin Cancer Res | 2023 | 37340443 | PubTator, text mining | PubMed |
| Circular RNAs in ferroptosis: regulation mechanism and potential clinical application in disease. | Front Pharmacol | 2023 | 37332354 | PubTator, text mining | PubMed |
| Expression of RNA-m6A-related genes correlates with the HIV latent reservoir level and the CD4+ and CD8+T cell profiles of patients with AIDS. | Cell Mol Biol (Noisy-le-grand) | 2023 | 37329536 | PubTator, text mining | PubMed |
| Microenvironment modulation by key regulators of RNA N6-methyladenosine modification in respiratory allergic diseases. | BMC Pulm Med | 2023 | 37328853 | PubTator, text mining | PubMed |
| High FAAP24 expression reveals poor prognosis and an immunosuppressive microenvironment shaping in AML. | Cancer Cell Int | 2023 | 37328842 | PubTator, text mining | PubMed |
| Helicobacter pylori promotes gastric intestinal metaplasia through activation of IRF3-mediated kynurenine pathway. | Cell Commun Signal | 2023 | 37328804 | PubTator, text mining | PubMed |
| RBM33: A new regulator of N-6-methyladenosine (m6A) methylation. | Mol Cell | 2023 | 37327770 | PubTator, text mining | PubMed |
| m6A reader proteins: the executive factors in modulating viral replication and host immune response. | Front Cell Infect Microbiol | 2023 | 37325513 | PubTator, text mining | PubMed |
| PIWI-interacting RNA-17458 is oncogenic and a potential therapeutic target in cervical cancer. | J Cancer | 2023 | 37325054 | PubTator, text mining | PubMed |
| ALKBH5-PYCR2 Positive Feedback Loop Promotes Proneural-Mesenchymal Transition Via Proline Synthesis In GBM. | J Cancer | 2023 | 37325047 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54890/papers?page=51